发布求助
文献互助 智能选刊 最新文献

US ophthalmic review最新文献

筛选
英文 中文
Descemet’s Membrane Endothelial Keratoplasty (DMEK)—Why Surgeons Should Consider Adopting Endothelium-in Techniques Descemet的膜内皮角膜移植术(DMEK) -为什么外科医生应该考虑采用内皮技术
US ophthalmic review Pub Date : 2019-01-01 DOI: 10.17925/usor.2019.12.2.65
H. Ong, J. Mehta, Corneal
{"title":"Descemet’s Membrane Endothelial Keratoplasty (DMEK)—Why Surgeons Should Consider Adopting Endothelium-in Techniques","authors":"H. Ong, J. Mehta, Corneal","doi":"10.17925/usor.2019.12.2.65","DOIUrl":"https://doi.org/10.17925/usor.2019.12.2.65","url":null,"abstract":"<p />","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67621774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Making the Perfect Winter Wonderland—A Case Report of Infectious Crystalline Keratopathy in the Setting of Chronic Nepafenac Use for Cystoid Macular Edema 打造完美的冬季仙境——慢性尼帕芬治疗黄斑囊样水肿并发感染性结晶性角膜病变1例报告
US ophthalmic review Pub Date : 2019-01-01 DOI: 10.17925/usor.2019.12.2.96
Luke Y. Chang, J. Hess, Z. Lukowski, Amy J. Estes
{"title":"Making the Perfect Winter Wonderland—A Case Report of Infectious Crystalline Keratopathy in the Setting of Chronic Nepafenac Use for Cystoid Macular Edema","authors":"Luke Y. Chang, J. Hess, Z. Lukowski, Amy J. Estes","doi":"10.17925/usor.2019.12.2.96","DOIUrl":"https://doi.org/10.17925/usor.2019.12.2.96","url":null,"abstract":"<p />","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67622407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Verteporfin Photodynamic Therapy for the Treatment of Choroidal Conditions—An Overview 维替泊芬光动力疗法治疗脉络膜疾病综述
US ophthalmic review Pub Date : 2019-01-01 DOI: 10.17925/usor.2019.12.2.69
J. Avaylon, R. Gallemore
{"title":"Verteporfin Photodynamic Therapy for the Treatment of Choroidal Conditions—An Overview","authors":"J. Avaylon, R. Gallemore","doi":"10.17925/usor.2019.12.2.69","DOIUrl":"https://doi.org/10.17925/usor.2019.12.2.69","url":null,"abstract":"<p />","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67621784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Recent Landmark Trials in Glaucoma 青光眼近期里程碑式试验综述
US ophthalmic review Pub Date : 2019-01-01 DOI: 10.17925/usor.2019.12.1.28
Eileen Choudhury, Joseph F. Panarelli
{"title":"A Review of Recent Landmark Trials in Glaucoma","authors":"Eileen Choudhury, Joseph F. Panarelli","doi":"10.17925/usor.2019.12.1.28","DOIUrl":"https://doi.org/10.17925/usor.2019.12.1.28","url":null,"abstract":"<p />","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67621680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flap Complications from Femtosecond Laser-assisted in Situ Keratomileusis 飞秒激光辅助原位角膜磨除术的皮瓣并发症
US ophthalmic review Pub Date : 2019-01-01 DOI: 10.17925/usor.2019.12.1.21
Steven H. Tucker, Priyanka Sood
{"title":"Flap Complications from Femtosecond Laser-assisted in Situ Keratomileusis","authors":"Steven H. Tucker, Priyanka Sood","doi":"10.17925/usor.2019.12.1.21","DOIUrl":"https://doi.org/10.17925/usor.2019.12.1.21","url":null,"abstract":"<p />","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67621672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Efficacy and Safety of Topical Cyclosporine in Dry Eye Subjects Who Engage in Electronic Visual Tasking—The EMPOWER Study 外用环孢素治疗干眼症患者电子视觉任务的有效性和安全性——EMPOWER研究
US ophthalmic review Pub Date : 2019-01-01 DOI: 10.17925/usor.2019.12.2.88
K. Stonecipher, G. Torkildsen, E. McLaurin, Linda Villanueva, G. Ousler, D. Hollander, Greensboro Nc Usa Tlc Laser Eye Centers
{"title":"Efficacy and Safety of Topical Cyclosporine in Dry Eye Subjects Who Engage in Electronic Visual Tasking—The EMPOWER Study","authors":"K. Stonecipher, G. Torkildsen, E. McLaurin, Linda Villanueva, G. Ousler, D. Hollander, Greensboro Nc Usa Tlc Laser Eye Centers","doi":"10.17925/usor.2019.12.2.88","DOIUrl":"https://doi.org/10.17925/usor.2019.12.2.88","url":null,"abstract":"<p />","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67622398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Discriminator and Diagnostic Features for Choroidal Malignant Melanoma and Choroidal Nevus 脉络膜恶性黑色素瘤和脉络膜痣的鉴别和诊断特征
US ophthalmic review Pub Date : 2018-01-01 DOI: 10.17925/usor.2018.11.1.47
B. Turgut, O. Çatak, T. Demir
{"title":"Discriminator and Diagnostic Features for Choroidal Malignant Melanoma and Choroidal Nevus","authors":"B. Turgut, O. Çatak, T. Demir","doi":"10.17925/usor.2018.11.1.47","DOIUrl":"https://doi.org/10.17925/usor.2018.11.1.47","url":null,"abstract":"Choroidal nevus and choroidal malignant melanoma, especially when they are small in size, may have similar ophthalmoscopic appearance. Additionally, though rarely, choroidal nevi may convert to malignant melanomas over several years. Early detection of a small choroidal malignant melanomas presents the risk of growth, and metastasis is extremely critical for the preservation of both vision and eye. Currently, the usage of the mnemonic TFSOM-HHD has been suggested to find small ocular melanomas using helpful hints daily. In this review, we aim to provide the main discriminator and diagnostic features for choroidal malignant melanoma and choroidal nevus.","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"11 1","pages":"47"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67620868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Emerging Treatments for Non-infectious Uveitis 非感染性葡萄膜炎的新兴治疗方法
US ophthalmic review Pub Date : 2018-01-01 DOI: 10.17925/USOR.2018.11.2.81
A. Banker, C. Pavesio, P. Merrill, B. Clinic
{"title":"Emerging Treatments for Non-infectious Uveitis","authors":"A. Banker, C. Pavesio, P. Merrill, B. Clinic","doi":"10.17925/USOR.2018.11.2.81","DOIUrl":"https://doi.org/10.17925/USOR.2018.11.2.81","url":null,"abstract":"The primary goals of treatment in patients with non-infectious uveitis (NIU) are to control ocular inflammation and prevent sight-threatening complications such as macular edema and glaucoma. Systemic corticosteroids are the mainstay of treatment in NIU of the posterior segment (NIU-PS); however, long-term use is associated with treatment-limiting adverse effects. The need for agents with improved safety and tolerability coupled with recent insights into the pathogenesis of NIU-PS have led to the development of novel targeted interventions that potentially reduce or eliminate systemic corticosteroid exposure. Targeted interventions include intraocular drug delivery systems that provide high local concentrations at the site of inflammation with low systemic exposure and therapeutic agents, such as monoclonal antibodies that target specific pro-inflammatory cytokines and cytokine-mediated signaling pathways. The expanding range of therapeutic options enhances the ability to tailor therapy according to individual patient circumstances and optimize outcomes in patients with NIU-PS.","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"15 1","pages":"81"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67622024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pediatric Nasolacrimal Duct Obstruction 小儿鼻泪管阻塞
US ophthalmic review Pub Date : 2018-01-01 DOI: 10.17925/USOR.2018.11.2.87
Shani Golan, G. Lelli
{"title":"Pediatric Nasolacrimal Duct Obstruction","authors":"Shani Golan, G. Lelli","doi":"10.17925/USOR.2018.11.2.87","DOIUrl":"https://doi.org/10.17925/USOR.2018.11.2.87","url":null,"abstract":"","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"11 1","pages":"87"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67622063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update in Vitreoretinal Instrumentation 玻璃体视网膜仪器的更新
US ophthalmic review Pub Date : 2018-01-01 DOI: 10.17925/USOR.2018.11.2.98
Gerardo González-Saldivar, D. Chow
{"title":"Update in Vitreoretinal Instrumentation","authors":"Gerardo González-Saldivar, D. Chow","doi":"10.17925/USOR.2018.11.2.98","DOIUrl":"https://doi.org/10.17925/USOR.2018.11.2.98","url":null,"abstract":"Disclosures: Gerardo González-Saldivar has nothing to declare in relation to this article. David R Chow declares the following financial interests or relationships: consultant/advisor for Alcon Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Dutch Ophthalmic Research Center (DORC) International USA and Katalyst; lecture fees for DORC International USA, OptoVue and Allergan; and equity ownership/stock options in public or privately traded firms, excluding mutual funds from Katalyst and Synergetics, Inc.","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"11 1","pages":"98"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67622087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信